ZyCoV-D
Zydus Cadila starts supply of COVID-19 vaccine to govt
ZyCoV-D is a three-dose vaccine administered intradermally
Centre places purchase order for Zydus Cadila's needle-free Covid vaccine
ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above
Zydus Cadila to reduce its Covid vaccine price to Rs 265 a dose, final decision soon
The company's Covid vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20
Cadila Healthcare gets DCGI nod to conduct phase 3 trials for two-dose COVID vaccine
The company has got the permission for conduct of phase III trials for two-dose Covid vaccine, Cadila Healthcare said in a regulatory filing
ZyCoV-D to be introduced in Covid vaccination drive shortly: Govt
ZyCoV-D has received the Emergency Use Authorisation from the Drugs Controller General of India (DCGI)
Zydus Cadila to seek approval for two-dose regimen of its approved three-dose vaccine
The trials for the two-dose regimen are underway
AA Edit | 3-dose jab a breather for govt, hope for the young
The needle-free vaccine has shown an efficacy of 66.6 per cent in a late-stage trial of over 28,000 volunteers nationwide
More clarity on ZyCOV-D vaccine price by next week, says Zydus Group MD Sharvil Patel
Zydus Cadila announced that once they get clearance then they are expected to supply 5 crores doses per month till December 21
Zydus Cadila's Covid vaccine ZyCoV-D gets approval for Emergency Use Authorisation
ZyCoV-D has become the first vaccine to be administered to those in the age group of 12-18 years in the country
Centre says Zydus Cadila's vaccines for children may be available in near future
Zydus Cadila has concluded its trial for children between the age group of 12 to 18